Results 91 to 100 of about 52,608 (252)

To Exercise at High Intensity Heart Rate or Not to Exercise at High Intensity Heart Rate?

Movement Disorders Clinical Practice, EarlyView.
Daniel M. Corcos, Guillaume Lamotte, Nijee S. Luthra, Kathleen E. McKee   +3 more
wiley   +1 more source

Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Diabetic retinopathy (DR) is linked to elevated risks of cerebrovascular diseases. Whether sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) reduce stroke risk in patients with type 2 diabetes (T2D) and DR remains uncertain. Materials and Methods We conducted a retrospective cohort study using the TriNetX Research Network.
Kuo‐En Chen, Po‐Chun Wang, Hui‐An Lin, Sheng‐Feng Lin   +3 more
wiley   +1 more source

Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops

Taiwanese Journal of Obstetrics & Gynecology, 2016
Objective: We report a case of nonimmune hydrops fetalis caused by atrial flutter, which was successfully treated by intraperitoneal and intra-amniotic injections of amiodarone.
Pei-Hsuan Lin, Hsin-Hung Wu, Horng-Der Tsai, Charles Tsung-Che Hsieh   +3 more
doaj   +1 more source

Comparison of performance achievement award recognition with primary stroke center certification for acute ischemic stroke care. [PDF]

, 2013
BackgroundHospital certification and recognition programs represent 2 independent but commonly used systems to distinguish hospitals, yet they have not been directly compared.
Fonarow, Gregg C, GWTG-Stroke Steering Committee & Investigators, Hernandez, Adrian F, Liang, Li, Peterson, Eric D, Reeves, Mathew J, Saver, Jeffrey L, Schwamm, Lee H, Smith, Eric E, Xian, Ying   +9 more
core   +2 more sources

Real‐World Selection of Venetoclax‐Obinutuzumab Versus BTK Inhibitor Therapy for Treatment‐Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

European Journal of Haematology, EarlyView.
ABSTRACT Introduction Novel targeted agents have transformed the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), including continuous BTK inhibitor (BTKi) therapy and time‐limited regimens such as venetoclax‐obinutuzumab (Ven‐O) and ibrutinib‐venetoclax (I + V).
Rebecca Tidswell, Carolyn Owen, Mona Shafey, Sarah Perry, Nanette Cox‐Kennett, Russell Sterrett, Anthea Peters, Robert Puckrin   +7 more
wiley   +1 more source

Flutter auricular atípico tardio após ablação de fibrilhação auricular

Revista Portuguesa de Cardiologia, 2016
Resumo: A existência de cardiopatia estrutural, a história de cirurgia cardíaca prévia (frequentemente envolvendo a aurícula esquerda) e a ablação percutânea da fibrilhação auricular conduziram a um aumento da incidência de taquicardias auriculares ...
Raquel Ferreira, João Primo, Luís Adão, Anabela Gonzaga, Helena Gonçalves, Rui Santos, Paulo Fonseca, José Santos, Vasco Gama   +8 more
doaj   +1 more source

Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives

European Journal of Haematology, EarlyView.
ABSTRACT Acalabrutinib, a second‐generation Bruton's tyrosine kinase inhibitor (BTKi), is characterized by enhanced specificity and selectivity for BTK with minimal off‐target effects, offering a significant evolution in the treatment of chronic lymphocytic leukemia (CLL). Its mechanism of action, a covalent binding to Cys481 within the BTK active site,
Gianluca Gaidano, Romano Danesi
wiley   +1 more source

Deepr: A Convolutional Net for Medical Records

, 2016
Feature engineering remains a major bottleneck when creating predictive systems from electronic medical records. At present, an important missing element is detecting predictive regular clinical motifs from irregular episodic records.
Nguyen, Phuoc, Tran, Truyen, Venkatesh, Svetha, Wickramasinghe, Nilmini   +3 more
core   +1 more source

Post‐marketing safety of CGRP monoclonal antibodies and gepants: A systematic review of spontaneous reporting system data

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective Calcitonin gene‐related peptide (CGRP) inhibitors, including monoclonal antibodies (mAbs) and small‐molecule antagonists (gepants), have transformed migraine treatment. Although clinical trials established their efficacy and initial safety, post‐marketing surveillance is essential for understanding their real‐world safety profile in ...
Martina Giacon, Salvatore Terrazzino
wiley   +1 more source

Laboratory and Medicine 2.1: Care for What You Wish for

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Over the past few decades, healthcare has made remarkable advances. Across nearly all fields, diseases are better understood, and diagnostic and therapeutic options have expanded dramatically. Laboratory medicine is also developing at a rapid pace and is playing an increasingly central role in the diagnostic process, as well as in the ...
Marcel Levi
wiley   +1 more source